interval from admission to onset, and interval from insertion of a central venous catheter 3 to onset were also examined. For patients transferred from other facilities, the duration 4 of hospital stay included the duration of hospitalization at both institutions. 5 6
Statistical analysis 7
Differences in the group proportions were assessed by using the chi-square or Fisher 8 exact test. Continuous variables were compared by using the Mann-Whitney test. 9
Statistical analyses were performed by using Prism version 5.0 (GraphPad, Inc., San 10 Diego, CA, USA). Differences were considered significant at a P value <0.05. 11 12
Results

Rate of contamination 1
Of the 126 MRSA isolates, 115 (91.3%) were considered infection associated and 11 2 (8.7%) were considered contamination. Of the 11 latter isolates, 9 were cultured from 3 blood and 2 were cultured from a closed abscess; the most common reason for 4 considering contamination was that the clinical symptoms and laboratory data improved 5 after treatment with an antimicrobial agent known to be ineffective against MRSA 6 infection, such as a β-lactam. Of the 209 MR-CoNS isolates, 83 (39.7%) were 7 considered infection associated and 126 (60.3%) were considered contamination. The 8
proportions of infection-associated or contaminant isolates for each specimen are shown 9 in Table 1 . These proportions remained the same even if the type of specimen was 10 limited to blood (39.6%). If only the initially cultured isolates from the blood of each 11 patient were evaluated, the proportion of infection decreased to 33.3%. MR-CoNS 12 isolates cultured from synovial fluid were significantly more likely to be infection 13 associated than isolates cultured from other specimens (5/83 vs. 0/126, P = 0.009). 14 Given the lack of criteria regarding clinical signs or symptoms in the definition of 15 CRBSI, we also confirmed clinical characteristics in patients with CRBSI to avoid 16 overestimating the incidence of infection. Of the 44 CRBSI-associated MR-CoNS 17 isolates in this study, 38 were obtained from patients with fever (≥38°C), 4 were 18 obtained from patients with hypotension (<90 mm Hg), and 3 were obtained from 1 patients with neutropenia (<500 cells/μL). Some patients had more than one of these 3 2
factors. 3
We also examined the possibility that the study population comprised patients with a 4 potentially higher risk of infection than the general hospital population. Of the 83 5 infection-associated MR-CoNS isolates, only 3 were obtained from patients in the 6 intensive care unit; 77 isolates were from patients in the general ward, and 3 isolates 7
were obtained from patients of the outpatient clinic. None of the study participants were 8 bone marrow transplant recipients. Twelve MR-CoNS isolates were obtained from 9 patients with hematologic malignancies. 10 11
MR-CoNS species 12
The proportions of each MR-CoNS species obtained from sterile sites are shown in 13 Table 4 . 8
The MRSA-infected patients were older than the MR-CoNS-infected patients (68.8 9 years versus 59.7 years, P = 0.016). The median interval from insertion of a central 10 venous catheter to the onset of infection tended to be longer in the cases of MR-CoNS 11 infection than in the cases of MRSA infection (41 days versus 14 days, P = 0.055). The 12 mortality rate with MRSA infection was 25%, which was higher than that with 13 MR-CoNS infection (2.9%, P = 0.016). Vital signs on the day of the positive blood 14 culture were similar. However, leukocyte counts and C-reactive protein levels tended to 15 In this study, we analyzed and compared various aspects of cases involving MRSA 9 and MR-CoNS cultures. Initially, we evaluated each positive culture obtained from 10 sterile sites to distinguish true infection from contamination because some CoNS 11 species are among the main species of normal resident skin flora (Roth and James, 12 1988). In this study, the percentage of MRSA contamination among blood cultures was 13 similar to that in a previous report (6.4%) (Weinstein, et al., 1997). 14 On the other hand, 39.7% of the MR-CoNS-positive cultures were considered true 15 infections, which is a higher proportion than previously reported (5%-30%) ( specimen types were included in our study, whereas previously published studies only 1 evaluated blood cultures. Even so, our results limited to blood cultures showed higher 2 infection rates compared with the results of previous studies. Second, the scope of our 3 study was limited to methicillin-resistant species. We chose to study 4 methicillin-resistant isolates only because this would enable precise decisions regarding 5 the presence or absence of a true infection, according to the requirement for anti-MRSA 6 drugs. Third, we adopted a definitive diagnosis of CRBSI that only required the growth 7 of the same organism from at least one percutaneous blood culture and a catheter tip 8 culture. However, we confirmed that most determinations of true infection-associated 9 CRBSI in this study met the requirements defined in previous studies, with regard to, 10 for example, clinical signs. Fourth, multiple samples may have been taken from the 11 same patient over a short interval. However, the proportion of cases of infection among 12 the initially cultured isolates from blood only in each patient remained higher than the 13 proportions reported in previous studies. Fifth, there was no evidence to indicate the 14 possibility that this study population might comprise patients at a potentially higher risk 15 of infection than the general hospital population, such as bone marrow transplant 16 recipients, patients with hematologic malignancies, and patients in intensive care units 17 (Herwaldt, et al., 1996) . These results indicated the possibility that the incidence of 18
CoNS infection may have increased in recent years compared with the rate in the 1990s. 1 This is not surprising because patient populations and treatment modes have changed 2 over time and, in particular, the rate of central venous catheterization has increased 3 (Glickman, et al., 2010). 4
One of the objectives of this study was to examine differences in the clinical 5 significance of MR-CoNS infection in blood and other sterile specimens. Most 6 specimens from sterile sites are normally collected via percutaneous puncture, and 7 therefore, microbes from the normal skin flora could likely contaminate those 8 specimens. We therefore expected that the infection-associated rates for each type of 9 specimen would be nearly identical. Indeed, most rates of contamination for other types 10 of specimens were similar to that in blood. However, an MR-CoNS-positive culture 11 from synovial fluid was more likely to be associated with infection. The pretest 12 probability for synovial fluid collection may be higher than that for other sterile 13 specimens (e.g., blood); however, the number of isolates in this study was small, and a 14 Conversely, S. haemolyticus and S. simulans were less likely to be infection associated 1 and were always considered contamination in this study. Herwaldt et al. indicated that 2 non-S. epidermidis species blood culture isolates were less likely to be infection 3 associated. Another potential concern in this study was the false identification of 4
Staphylococcus species. MicroScan WalkAway, which was used for identification, has 5 been reported to have poor reliability for some uncommon CoNS strains (Olendzki, et 6 al., 2014). Unlike other species, the identification of S. epidermidis, S. haemolyticus, 7 and S. hominis was reported to be sufficiently reliable in the same study. The authors 8 also reported that the automated system showed 100% specificity and 90% sensitivity 9 for the detection of oxacillin resistance. Our results indicate the need for careful 10 evaluation, especially for uncommon CoNS strains. 11
In our study, rates of hospital-acquired infection were higher than those in previous 12 studies (Beekmann, et 
